log in
Print | Back

Lowenstein Sandler LLP

Robert J. Paradiso

Robert J. Paradiso

Chair, Chemicals & Life Sciences Patent Practice


  • Intellectual Property & Patents
  • Corporate
  • Life Sciences
  • Patent Counseling & Prosecution

WSG Practice Industries


Lowenstein Sandler LLP
New Jersey, U.S.A.


Robert's practice is focused on the life sciences and chemical industries. Over the course of his career, he has counseled clients on the discovery, design, and protection of many successful therapeutic and diagnostic products with important commercial and humanitarian benefits. He is recognized by Chambers USA (2012-2017) as a "phenomenal" lawyer and "practical, strategic thinker" who "is very good at thinking outside the box and looking at every angle and advising on how to best move forward."

As a registered pharmacist, Robert is able to speak the same language as the researchers, managers, and investors with whom he interacts daily. He is particularly adept at analyzing complex issues and effectively crafting, communicating, and implementing solutions that achieve his clients' goals–whether for raising capital, closing the deal, or obtaining a bet-the-company patent.

Clients benefit from Robert's significant experience in virtually all aspects of intellectual property law, including:

  • Patent prosecution
  • Noninfringement
  • Patentability
  • Litigation
  • Freedom to operate
  • Technology transfer

He also regularly advises clients on product acquisition and divestiture, joint ventures and alliances, technology licensing, outsourcing, and other technology-related transactions.

Robert serves as an adjunct professor at Seton Hall University School of Law School, where he teaches patent drafting and prosecution.

Bar Admissions

    New York
    New Jersey
    United States Patent and Trademark Office


St. John's University School of Law (J.D. 1994)
Long Island University (B.S. 1990), Pharmacy
Areas of Practice

Corporate | Intellectual Property & Patents | Life Sciences | Patent Counseling & Prosecution | Patents | Privacy & Cybersecurity | Seed Stage Investing & Startups | Technology & Media Transactions | The Tech Group | Trademarks, Copyrights & Trade Secrets | Venture Capital & Tech M&A

Professional Career

Significant Accomplishments

Obtained a groundbreaking patent that is listed in the FDA Orange Book for a tamper-resistant formulation of an FDA-approved narcotic analgesic.

Obtained Orange Book-listed patents for a specialty pharmaceutical company specializing in acute hospital care. The patents encompass four currently marketed formulations of an injectable antihypertensive product and were the driving force for the eventual acquisition of the company.

Obtained multiple patents covering a Phase III injectable product for the treatment of adverse effects of chemotherapy.

Represented a leading U.S. medical school in prosecuting and procuring patents directed to specialized tests that are capable of detecting latent tuberculosis in patients.

Performed an IP analysis for a leading financial services firm in connection with an investment in a biopharmaceutical company developing a genetically personalized therapeutic agent.

Speaking Engagements

Robert J. Paradiso will be conducting an Intellectual Property seminar for the New Jersey Chapter of the National Society of Inventors.  He will be discussing the patent process, strategies to overcome patent office rejections, and general considerations in the development of patent assets.

This meeting is free and open to the public.


  • Inventor Networking: 6:30-8:00 p.m.
  • New Member Orientation: 7:00 p.m.
  • Meeting with Seminar: 8:00-9:00 p.m.

Location: Costa’s Restaurant, 120 Chestnut Street, Roselle Park, NJ 07204

Professional Activities and Experience

  • Chambers USA: America's Leading Lawyers for Business (2012-2020) - PARADISO
  • Intellectual Asset Management (IAM) Patent 1000 - Robert Paradiso


    Abbott Labs v. Sandoz: The Federal Circuit Provides Clarity On Product-By-Process Claims, February 1, 2010
    Avoiding Pitfalls In IP Licensing, March 2009
    Dilemmas of Joint Patent Ownership, September 2009
    District Court Holds Myriad’s Gene Patents Invalid, June 2010
    Drafting Method-of-Treatment Claims, April 11, 2011
    Federal Circuit Affirms Ruling of USPTO Error In Calculating Patent Term Adjustment, April 12, 2010
    Laws of Nature: Myriad and the Prometheus Impact, June 1, 2012
    Patent Reform Bill Criticized, September 13, 2007
    The Impact of Proposed Patent Reform on the Life Sciences Industry, April 14, 2008
    Think Twice Before Filing That CIP Application, April 13, 2009


Capital Markets Litigation
Lowenstein Sandler LLP 

Litigation News for the Global Financial Community

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020